Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exocyst complex component 5 pseudogene 1 (EXOC5P1) is a human pseudogene with high sequence similarity to the protein-coding EXOC5 gene. EXOC5 itself encodes a protein that is a key component of the exocyst complex, a highly conserved octameric complex responsible for tethering and targeting exocytic vesicles to specific docking sites at the plasma membrane, which is essential for processes such as cell polarity, membrane trafficking, and exocytosis[1][3][4]. In contrast, as a pseudogene, EXOC5P1 does not encode a functional protein and is not considered a receptor, enzyme, transporter, or direct therapeutic target[2][5]. Pseudogenes like EXOC5P1 can sometimes have regulatory functions or be involved in disease-related processes (e.g., acting as microRNA decoys or influencing gene expression), but no specific functional or clinical data are available for EXOC5P1 itself[2][5]. There is currently no evidence that EXOC5P1 interacts directly with any drugs, serves as a biomarker, or presents known safety concerns for therapeutic use. - EXOC5P1 is *not* a canonical protein-coding target and is classified as a pseudogene; there may be confusion or incorrect listings if it's proposed as a target for drug development, biomarker, or genetic studies seeking receptor, enzyme, or other pharmacologically actionable entities. - While some pseudogenes are being explored as non-coding RNA regulators, their role is case-dependent and no evidence for EXOC5P1 as a regulatory molecule in disease or health is currently established in the literature[2][5]. If you need structured biomedical target data, EXOC5 (not EXOC5P1) is the canonical exocyst complex protein, but EXOC5P1 is an uncharacterized pseudogene and does not meet the criteria for a canonical drug target or receptor[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exocyst complex component 5 pseudogene 1 (EXOC5P1).